Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

Learn how weight loss, diet changes and regular exercise can help manage — and sometimes reverse — fatty liver disease when ...

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

Cytotheryx, a preclinical cell therapy company developing treatments for liver disease, is receiving $60 million in Series A ...

More than 30% of people worldwide have metabolic dysfunction–associated steatotic liver disease (MASLD; formerly nonalcoholic fatty liver disease), including 65% of those with type 2 diabetes (T2D) ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...

Explore the rising concern of MASLD in India, emphasizing the need for proactive screening and lifestyle changes for ...

Scientists hope to ‘tackle the disease at its beginnings’ after a genetic breakthrough.

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

Are you a late-night snack lover? Well, researchers at the University of Oxford have discovered that the most common liver ...